Showing results (621-630 of 656) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2019
Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-conceptJacob P R Jacobsen, Adrianna Oh, Rachel Bangle, et al.
Journal of Medicinal Chemistry|August 8, 2019
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric ModulatorsAnthony B Pinkerton, Satyamaheshwar Peddibhotla, Fusayo Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Imidazole-derived agonists for the neurotensin 1 receptorPaul M Hershberger, Michael P Hedrick, Satyamaheshwar Peddibhotla, et al.
Gastroenterology|May 10, 2019
Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of DepressionNarek Israelyan, Andrew Del Colle, Zhishan Li, et al.
Genes, Brain, and Behavior|September 10, 2008
Reduced expression of the vesicular acetylcholine transporter causes learning deficits in miceB M de Castro, G S Pereira, V Magalhães, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2022
Discovery of a functionally selective ghrelin receptor (GHSR1a) ligand for modulating brain dopamineJ D Gross, D W Kim, Y Zhou, et al.
ACS Chemical Biology|April 28, 2016
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine AbuseLarry S Barak, Yushi Bai, Sean Peterson, et al.
Science (New York, N.Y.)|January 22, 2021
Noncanonical scaffolding of Gαi and β-arrestin by G protein-coupled receptorsJeffrey S Smith, Thomas F Pack, Asuka Inoue, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2016
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-onesMaria Elena Meza-Aviña, Mary A Lingerfelt, Linda M Console-Bram, et al.
Pageof 66